Biosynthesis of polyunsaturated fatty acids in lower eukaryotes

Area of Science:

• Biochemistry
• Molecular Biology
• Microbiology

Background:

• Polyunsaturated fatty acids (PUFAs) are crucial for cell membrane structure and synthesizing bioactive molecules like eicosanoids.
• Arachidonic and docosahexaenoic acids are essential for neonatal brain and retinal development, highlighting their importance as dietary nutrients.
• Lower eukaryotes, including fungi, microalgae, and protists, are rich sources of C20-22 PUFAs and possess diverse enzymes for their biosynthesis.

Purpose of the Study:

• To explore the enzymatic pathways and diversity of polyunsaturated fatty acid (PUFA) biosynthesis in lower eukaryotes.
• To identify potential applications of PUFA biosynthesis enzymes, such as producing nutraceuticals via transgenic organisms or discovering chemotherapeutic targets in parasitic protozoa.
• To provide a detailed description of isolated and characterized desaturase enzymes involved in PUFA synthesis.

Main Methods:

• Analysis of enzymatic pathways for PUFA synthesis, including anaerobic (polyketide synthase-related) and aerobic (elongases and desaturases) routes.
• Classification of desaturases into three types (I, II, III) based on their substrate specificity and position of double bond introduction.
• Isolation and functional characterization of specific enzymes involved in PUFA biosynthesis within various lower eukaryotic organisms.

Main Results:

• Lower eukaryotes exhibit significant variability in PUFA biosynthesis enzymes, offering a rich resource for biotechnological applications.
• Desaturase enzymes can be categorized into three types, each playing a distinct role in introducing double bonds during PUFA synthesis.
• The study details specific enzymes and highlights the distinct PUFA synthesis pathways present in different lower eukaryotic species.

Conclusions:

• Enzymes from lower eukaryotes involved in polyunsaturated fatty acid biosynthesis present significant opportunities for developing novel nutraceuticals and therapeutic strategies.
• Understanding the diverse enzymatic machinery in lower eukaryotes is key to harnessing their potential for producing designer oils and identifying drug targets.
• Further characterization of these enzymes can lead to advancements in biotechnology, human nutrition, and medicine.